Perioperative management of anticoagulation: Guidelines translated for the clinician

Journal of Thrombosis and Thrombolysis

Volumn 28, Issue 1, 2009, Pages 16-22

  Kraai, Erik P ^a   Lopes, Renato D ^b   Alexander, John H ^b   Garcia, David ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Anticoagulation; Bridging therapy; Perioperative management; Vitamin K antagonists

Indexed keywords

ANTIVITAMIN K; DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; TINZAPARIN; WARFARIN;

ANTICOAGULATION; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; DEEP VEIN THROMBOSIS; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; HEART ATRIUM FIBRILLATION; HEART VALVE PROSTHESIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; LOW DRUG DOSE; LUNG EMBOLISM; MORBIDITY; MORTALITY; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RISK FACTOR; THROMBOEMBOLISM; THROMBOSIS; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; HUMANS; PERIOPERATIVE CARE; PRACTICE GUIDELINES AS TOPIC; VITAMIN K;

EID: 67449107188     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-009-0313-7     Document Type: Article

References (28)

1. Douketis JD, Berger PB, Dunn AS et al (2008) The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed). Chest 133:299S-339S. doi: 10.1378/chest.08-0675
2. Miyasaka Y, Barnes ME, Gersh BJ et al (2006) Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 114:119-125. doi: 10.1161/CIRCULATIONAHA.105.595140
3. O'Donnell M, Kearon C (2008) Perioperative management of oral anticoagulation. Cardiol Clin 26:299-309. doi: 10.1016/j.ccl.2007.12.012
4. Dunn AS, Turpie AG (2003) Perioperative management of patients receiving oral anticoagulants: A systematic review. Arch Intern Med 163:901-908. doi: 10.1001/archinte.163.8.901
5. Guyatt GH, Cook DJ, Jaeschke R et al (2008) Grades of recommendation for antithrombotic agents: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed). Chest 133:123S-131S. doi: 10.1378/chest.08-0654
6. Palareti G, Legnani C, Guazzaloca G et al (1994) Activation of blood coagulation after abrupt or stepwise withdrawal of oral anticoagulants-a prospective study. Thromb Haemost 72:222-226
7. Björk VO, Henze A (1975) Management of thrombo-embolism after aortic valve replacement with the Björk-Shiley tilting disc valve. Medicamental prevention with dicumarol in comparison with dipyridamole-acetylsalicylic acid. Surgical treatment of prosthetic thrombosis. Scand J Thorac Cardiovasc Surg 9:183-191
8. Jaffer AK, Brotman DJ, Chukwumerije N (2003) When patients on warfarin need surgery. Cleve Clin J Med 70:973-984
9. Gage BF, Waterman AD, Shannon W et al (2001) Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 285:2864-2870. doi: 10.1001/ jama.285.22.2864
10. Garcia DA, Regan S, Henault LE et al (2008) Risk of thromboembolism with short-term interruption of warfarin therapy. Arch Intern Med 168:63-69. doi: 10.1001/archinternmed.2007.23
11. Wysokinski WE, McBane RD, Daniels PR et al (2008) Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation. Mayo Clin Proc 83:639-645
12. Kovacs MJ, Kearon C, Rodger M et al (2004) Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation 110:1658-1663. doi: 10.1161/01.CIR.0000142859.77578.C9
13. Linkins LA, Choi PT, Douketis JD (2003) Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: A meta-analysis. Ann Intern Med 139:893-900
14. Douketis JD, Johnson JA, Turpie AG (2004) Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: Assessment of a standardized periprocedural anticoagulation regimen. Arch Intern Med 164:1319-1326. doi: 10.1001/archinte.164.12.1319
15. Ihezue CU, Smart J, Dewbury KC et al (2005) Biopsy of the prostate guided by transrectal ultrasound: Relation between warfarin use and incidence of bleeding complications. Clin Radiol 60:459-463. doi: 10.1016/j.crad.2004.10.014
16. Sorbi D, Norton I, Conio M et al (2000) Postpolypectomy lower GI bleeding: Descriptive analysis. Gastrointest Endosc 51:690-696. doi: 10.1067/mge.2000.105773
17. Wiegand UK, LeJeune D, Boguschewski F et al (2004) Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: Influence of patient morbidity, operation strategy, and perioperative antiplatelet/ anticoagulation therapy. Chest 126:1177-1186. doi: 10.1378/ chest.126.4.1177
18. Thumboo J, O'Duffy JD (1998) A prospective study of the safety of joint and soft tissue aspirations and injections in patients taking warfarin sodium. Arthritis Rheum 41:736-739. doi: 10.1002/ 1529-0131(199804)41:4<736::AID-ART23>3.0.CO;2-P
19. Eisen GM, Baron TH, Dominitz JA et al (2002) Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastrointest Endosc 55:775-779. doi: 10.1016/S0016-5107(02)70402-1
20. Lee SY, Tang SJ, Rockey DC et al (2008) Managing anticoagulation and antiplatelet medications in GI endoscopy: A survey comparing the East and the West. Gastrointest Endosc 67:1076-1081. doi: 10.1016/ j.gie.2007.11.037
21. White RH, McKittrick T, Hutchinson R et al (1995) Temporary discontinuation of warfarin therapy: Changes in the international normalized ratio. Ann Intern Med 122:40-42
22. Spyropoulos AC, Turpie AG, Dunn AS et al (2008) Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry). Am J Cardiol 102:883-889. doi: 10.1016/j.amjcard.2008.05.042
23. Kovacs MJ, Kearon C, Rodger M et al (2004) Single-Arm study of Bridging Therapy with low molecular weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation 110(12):1658-1663. doi: 10.1161/01.CIR.0000142859.77578.C9
24. Dunn AS, Spyropoulos AC, Turpie AG (2007) Bridging therapy in patients on long-term oral anticoagulants who require surgery: The Prospective Peri-operative Enoxaparin Cohort Trial (PROSPECT). J Thromb Haemost 5:2211-2218. doi: 10.1111/j.1538-7836.2007.02729.x
25. Bemiparin Randomized Trial on Bridging Oral Anticoagulants in Invasive Procedures (BERTA Study). NCT00484822. http://clinicaltrials.gov/ct2/ show/NCT00484822?term=NCT00484822&rank=1. Accessed 11 Nov 2008
26. Patients Preference with Self-Injection: The PRISM Study. NCT00253396. http://clinicaltrials.gov/ct2/show/ NCT00253396?term=nct00253396&rank=1. Accessed 11 Nov 2008
27. PERIOP 2 - A Safety and Effectiveness Study of LMWH Bridging Therapy Versus Placebo Bridging Therapy for Patients on Long Term Warfarin and Require Temporary Interruption of Their Warfarin. NCT00432796. http://clinicaltrials.gov/ct2/show/ NCT00432796?term=nct00432796&rank=1. Accessed 11 Nov 2008
28. Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study). NCT00786474. http://clinicaltrials.gov/ct2/show/NCT00786474?term= nct00786474&rank=1. Accessed 11 Nov 2008